CAR T-cell therapy is a groundbreaking, one-time therapy that uses versions of your own immune cells to find and destroy tough-to-treat blood cancers, such as multiple myeloma and leukemia.
At BMC's CAR T-cell Therapy Program, we offer the same state-of-the-art CAR T-cell therapies as larger institutions, but with a more personalized approach that takes into account all of your medical needs and life circumstances. Together, our multidisciplinary team of experts is breaking down barriers to cancer treatment and providing all the care you need throughout your journey.
Our program is led by Fabio Petrocca, MD, a world-renowned expert in CAR T-cell therapies. Along with Petrocca, providers from specialties across the hospital have joined the CAR T-cell Therapy Program because they understand the importance of providing equitable access to this life-saving treatment for all patients who may benefit from it.
Frequently Asked Questions About CAR T-cell Therapy
La historia de Arminta
Arminta Graham siempre le dice a todo el mundo: "La terapia de células T con CAR es lo mejor que me ha pasado". Pero cuando le ofrecieron el tratamiento por primera vez, no estaba segura de aceptarlo. Pronto cambió de opinión y se convirtió en la primera paciente de BMC en recibir esta terapia que le salvó la vida.
Afecciones que tratamos
Mieloma múltiple
Non-Hodgkin Lymphoma
Leukemia
Nuestro equipo
The CAR T-cell Therapy Program at BMC brings together the expertise of a wide range of specialists. Led by Dr. Fabio Petrocca, a world-renowned expert in CAR T-cell therapy, our multidisciplinary team provides coordinated care between hematology, critical care, neurology, cardiology, blood bank, laboratory medicine, social work, pharmacy, and emergency medicine.